Picture of KALA BIO logo

KALA — KALA BIO News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Kala Reports First Quarter 2022 Financial Results And Provides Corporate Update

Kala Pharmaceuticals Inc  KALA.O :
    * KALA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.45
    * Q1 EARNINGS PER SHARE VIEW $-0.36 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX75BBSP 
Further company coverage:  KALA.O

Recent news on KALA BIO

See all news